Skip to main
CLX
CLX logo

Clorox (CLX) Stock Forecast & Price Target

Clorox (CLX) Analyst Ratings

Based on 25 analyst ratings
Hold
Strong Buy 12%
Buy 8%
Hold 56%
Sell 20%
Strong Sell 4%

Bulls say

Clorox has demonstrated a robust financial performance, exceeding internal sales expectations particularly in the Health & Wellness and International segments, attributed to increased consumption and favorable product mix. The company's earnings per share (EPS) of $1.86 significantly surpassed consensus estimates of $1.37, indicating strong profitability. Furthermore, Clorox has shown consistent market share growth across its various product categories for two consecutive quarters, reinforcing a positive outlook for future top-line growth.

Bears say

Clorox's stock outlook is negatively impacted by several fundamental factors, including anticipated organic sales growth remaining at the low end of the low single digits (+0-1%), primarily due to challenging comparisons from last year's recovery after a cybersecurity incident. Additionally, the company is facing supply chain challenges in key product categories such as bags and cat litter, which could further hinder the recovery of dollar sales and potential market share. Moreover, the rising risks associated with input costs and the highly competitive landscape in the consumer products sector underscore concerns about Clorox's ability to maintain profit margins and brand strength moving forward.

Clorox (CLX) has been analyzed by 25 analysts, with a consensus rating of Hold. 12% of analysts recommend a Strong Buy, 8% recommend Buy, 56% suggest Holding, 20% advise Selling, and 4% predict a Strong Sell.

This aggregate rating is based on analysts' research of Clorox and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Clorox (CLX) Forecast

Analysts have given Clorox (CLX) a Hold based on their latest research and market trends.

According to 25 analysts, Clorox (CLX) has a Hold consensus rating as of Jul 1, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $146.60, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $146.60, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Clorox (CLX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.